Both are overwhelmingly preclinical for recovery
For chronic tendinopathies, micro-dosing provides sustained support for the gradual remodeling process these tissues require
The mechanisms, dosing, and effects are the same
Proper pharmacy licensing, prescription oversight, quality systems, and clinical monitoring can reduce some risks, but they do not replace the controlled trials and premarket review required for FDA approval of a specific drug product
Key Potential Benefits Joint Pain & Arthritis Support: Could be used to decrease the inflammation, swelling, stiffness, and discomfort in dogs with osteoarthritis or other age-related complications
We agree that this measure addresses an important measurement area, that this measure can provide valuable feedback to clinicians about their communication practices, and it can highlight areas of needed improvement